Quest Diagnostics (NYSE:DGX) Given Hold Rating at Truist Financial

Truist Financial reissued their hold rating on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report published on Wednesday, Benzinga reports. They currently have a $145.00 price objective on the medical research company’s stock. A number of other research analysts also recently weighed in on the company. UBS Group raised their price objective […]

Related Keywords

United States ,Kentucky ,Wellington ,New Zealand General ,New Zealand ,Pine Valley ,Michaele Prevoznik ,Vickyb Gregg , ,Quest Diagnostics Incorporated ,Quest Diagnostics Company Profile ,Massmutual Trust Co ,Quest Diagnostics ,Kentucky Retirement Systems Insurance Trust Fund ,Barclays ,Citigroup ,Invesco Ltd ,Pine Valley Investments Ltd Liability Co ,Wellington Management Group ,Truist Financial ,Free Report ,Get Free Report ,Director Vicky ,Retirement Systems Insurance Trust Fund ,Management Group ,Diagnostics Incorporated ,Quest Diagnostics Daily ,Nyse Dgx ,Dgx ,Medical ,74834l10 ,Reiterated Rating ,Truist Financial Co ,